October 2010 Issue - Endovascular Today

Table of Contents

Issue

October 2010

CAS Data and Decisions

In-depth analyses of CREST and other major carotid revascularization trials, and how their results will affect practices around the world.

Supplement

What keeps an AAA endovascular graft from migrating?

What features do physicians value in migration resistance for AAA endovascular grafts?

View Supplement

In This Issue

CHIEF MEDICAL EDITOR'S PAGE: The CAS Data Puzzle

By William A. Gray, MD, and Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD

Cover Stories

A Summary of the CREST Trial

This trial was designed to meet the need for a sufficient comparison of CAS and CEA for patients with carotid atherosclerosis.

By Rita Coram, MD, and Alex Abou-Chebl, MD

Contemporary Randomized Trials Comparing CAS and CEA

A critique of the EVA-3S, SPACE, ICSS, SAPPHIRE, and CREST studies.

By Sumaira Macdonald, MBCHB (COMM.), FRCP, FRCR, PHD

Perspectives on the Current State of Major Carotid Revascularization Trials

A multidisciplinary roundtable of carotid experts discusses recent trial data, difficulties in comparative analyses, the search for definitive conclusions, and the new questions arising with every published dataset.

By William A. Gray, MD; L. Nelson Hopkins, MD; Barry T. Katzen, MD, FACC, FACR, FSIR; Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD; and Frank J. Veith, MD

Minor Stroke Versus CNI in CREST

Cranial nerve injury should be included in a 30-day neurological outcomes composite endpoint in carotid revascularization.

By Mandy J. Binning, MD, and L. Nelson Hopkins, MD

Cranial nerve injuries are not the equivalent of strokes, but what is their bearing on CREST?

By Frank J. Veith, MD

Does MI Matter? A critical analysis of the CREST trial results: A surgeon's perspective.

By Wesley S. Moore, MD

Does MI Matter? Understanding the endpoint analysis in CREST.

By William A. Gray, MD

Applying CREST to Clinical Practice

With further collaboration among specialties and careful consideration of the available data, CAS performed by experienced operators may become accepted as frontline therapy in properly selected patients.

By Chris Metzger, MD

Featured Technology

Sponsored by Boston Scientific Corporation

The Tailored Approach To CAS

By Alberto Cremonesi, MD; Chiara Grattoni, MD; Federico Colombo, MD; Andrea Zuffi, MD; and Fausto Castriota, MD

Randomized Trials for Standard Risk/High-Risk Population.

Symptomatic/Mixed

Randomized Trials for Standard-Risk Population.

Asymptomatic

Postmarket Surveillance Registries.

High Surgical Risk. Symptomatic/Mixed.

Premarket Approval Registries.

High Surgical Risk. Mixed.

Challenging Cases

Inadvertent Innominate Artery Puncture Repair

Using the StarClose vascular closure device to repair the unintended placement of a dual-lumen catheter without surgery.

By Mojtaba Gashti, DO, FACOS; Jason M. Radecke, MD; AND Marc Curvin

Techniques

Conduit Use During Endovascular Repair of AAAs

A case report and review of the techniques.

By Richard C. Hershberger, MD, and Ross Milner, MD

Departments

Innovations

A preview of today's new products

An Interview with J. Michael Tuchek, DO

How the field of cardiovascular surgery is changing in light of new technology and its ever-increasing coordination with interventional cardiology.

October 2010 Supplement

What keeps an AAA endovascular graft from migrating?

What features do physicians value in migration resistance for AAA endovascular grafts?

View Supplement View Supplement

Latest Issues

April 2026

March 2026

February 2026

January 2026

December 2025

View All Issues

In This Issue

October 2010 Supplement

Most Read Articles